what’s your point?
we are more than happy with our “small niche market” of 3,000,000 US asthmatic children.
the annual revenue from 50-100k units would likely result in 10x share price upside + make the company a prime takeover candidate from a large global coy in the space.
A 2.5% share of a “small niche market” that is achievable vs “massive revenue potential” that is delusional......I know which one I would prefer.
Ann: Respiri enters Distribution/Marketing Agreement in USA, page-36
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400000 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 199999 | 1 |
View Market Depth
| Last trade - 16.12pm 04/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable